p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast.

scientific article

p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1012358809
P356DOI10.1007/S13402-012-0071-Y
P932PMC publication ID3306558
P698PubMed publication ID22354696
P5875ResearchGate publication ID221851521

P50authorPeter BultQ57159574
P2093author name stringPatrick W B Derksen
Paul J van Diest
Elsken van der Wall
Horst Buerger
Cigdem Ercan
John Hinrichs
Bram van der Ende
P2860cites workSomatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.Q53588886
Silent mutations in the gene encoding the p53 protein are preferentially located in conserved amino acid positions and splicing enhancers.Q53625030
The pathologist and breast cancer screeningQ68540308
Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitroQ68584387
Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factorsQ69502371
Infiltrating lobular carcinoma of the breastQ70338114
Accumulation of p53 protein as an indicator for p53 gene mutation in breast cancer. Occurrence of false-positives and false-negativesQ72721734
Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysisQ73299094
Molecular and immunohistochemical analysis of p53 mutations in scrapings and tissue from preinvasive and invasive breast cancerQ74039261
Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 casesQ77363572
P53 in breast carcinomas: association between presence of mutation and immunohistochemical expression using a semiquantitative approachQ77811298
The price of silent mutationsQ83960871
Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancerQ84150530
Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 casesQ94153774
The p53 pathway in breast cancerQ24802349
p53 mutations in human cancersQ28302973
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 databaseQ29616468
Mutations in p53, p53 protein overexpression and breast cancer survivalQ33703486
Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategiesQ34400583
No consent should be needed for using leftover body material for scientific purposes. For.Q34872356
P53 mRNA controls p53 activity by managing Mdm2 functionsQ34927261
Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in miceQ34990925
Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysisQ35168290
p53 mutations and expression in breast carcinoma in situQ35793421
Prognostic significance of TP53 alterations in breast carcinomaQ35976693
The R72P P53 mutation is associated with familial breast cancer in Jewish womenQ36616536
Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysisQ36620640
European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary documentQ37007574
Mutations in p53 as potential molecular markers for human breast cancerQ37632816
Nuclear accumulation of p53 protein correlates with mutations in the p53 gene on archival paraffin-embedded tissues of human breast cancerQ38483058
Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast CancersQ38487557
Mutant p53 drives invasion by promoting integrin recyclingQ39753731
Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomasQ43818075
P53 codon 72 polymorphism in breast cancerQ44396389
Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese womenQ44926364
p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parametersQ45574486
p53 as a specific prognostic factor in triple-negative breast cancerQ46079292
The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern GreeceQ46443444
Pleomorphic variant of invasive lobular carcinoma of the breastQ46459050
Evidence for selective expression of the p53 codon 72 polymorphs: implications in cancer developmentQ46711410
Role of a p53 polymorphism in the development of human papillomavirus-associated cancerQ48024470
Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiationQ48646405
P433issue2
P921main subjectinvasive lobular carcinomaQ929221
P1104number of pages8
P304page(s)111-118
P577publication date2012-02-22
P1433published inCellular OncologyQ2160503
P1476titlep53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast
P478volume35

Reverse relations

cites work (P2860)
Q36468724Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study
Q42577135Comparison of intramedullary myeloma and corresponding extramedullary soft tissue plasmacytomas using genetic mutational panel analyses
Q39285924IPH-926 lobular breast cancer cells harbor a p53 mutant with temperature-sensitive functional activity and allow for profiling of p53-responsive genes
Q50923528Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinoma.
Q33802722Lectin histochemistry reveals SNA as a prognostic carbohydrate-dependent probe for invasive ductal carcinoma of the breast: a clinicopathological and immunohistochemical auxiliary tool
Q35059856Lobular breast cancer: molecular basis, mouse and cellular models
Q38130105Lobular breast cancer: pathology, biology, and options for clinical intervention
Q54317130Methylation biomarkers for pleomorphic lobular breast cancer - a short report.

Search more.